Aclarion Notifies Availability of Press Release on Nociscan Clinical Use Abstracts

Aclarion, Inc.

Aclarion, Inc.

ACON

0.00
  • Aclarion posted a new press release on July 21, 2026 on Nociscan real-world use presented at the ASPN annual meeting.
  • Early experience from a 20-patient workflow study reported Nociscan integration into clinical practice for identifying symptomatic lumbar discs.
  • A case study used Nociscan to guide basivertebral nerve ablation without classic Modic MRI changes, reporting 95% pain relief at two weeks.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aclarion Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607210700PRIMZONEFULLFEED9765104) on July 21, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.